Literature DB >> 26919170

Embracing proteins: structural themes in aptamer-protein complexes.

Amy D Gelinas1, Douglas R Davies2, Nebojsa Janjic3.   

Abstract

Understanding the structural rules that govern specific, high-affinity binding characteristic of aptamer-protein interactions is important in view of the increasing use of aptamers across many applications. From the modest number of 16 aptamer-protein structures currently available, trends are emerging. The flexible phosphodiester backbone allows folding into precise three-dimensional structures using known nucleic acid motifs as scaffolds that orient specific functional groups for target recognition. Still, completely novel motifs essential for structure and function are found in modified aptamers with diversity-enhancing side chains. Aptamers and antibodies, two classes of macromolecules used as affinity reagents with entirely different backbones and composition, recognize protein epitopes of similar size and with comparably high shape complementarity.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 26919170     DOI: 10.1016/j.sbi.2016.01.009

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  48 in total

Review 1.  Beyond DNA and RNA: The Expanding Toolbox of Synthetic Genetics.

Authors:  Alexander I Taylor; Gillian Houlihan; Philipp Holliger
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-06-03       Impact factor: 10.005

2.  Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B.

Authors:  Xin Xu; Chi Zhang; Dalton T Denton; Daniel O'Connell; Daniel W Drolet; Brian V Geisbrecht
Journal:  J Immunol       Date:  2021-01-08       Impact factor: 5.422

3.  Evolution of abiotic cubane chemistries in a nucleic acid aptamer allows selective recognition of a malaria biomarker.

Authors:  Yee-Wai Cheung; Pascal Röthlisberger; Ariel E Mechaly; Patrick Weber; Fabienne Levi-Acobas; Young Lo; Alvin W C Wong; Andrew B Kinghorn; Ahmed Haouz; G Paul Savage; Marcel Hollenstein; Julian A Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-06       Impact factor: 11.205

Review 4.  Aptamers isolated against mosquito-borne pathogens.

Authors:  Tholasi Nadhan Navien; Tzi Shien Yeoh; Andrew Anna; Thean-Hock Tang; Marimuthu Citartan
Journal:  World J Microbiol Biotechnol       Date:  2021-07-09       Impact factor: 3.312

Review 5.  Tapping the RNA world for therapeutics.

Authors:  Judy Lieberman
Journal:  Nat Struct Mol Biol       Date:  2018-04-16       Impact factor: 15.369

6.  Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers.

Authors:  Angelo Moreno; George A Pitoc; Nancy J Ganson; Juliana M Layzer; Michael S Hershfield; Alice F Tarantal; Bruce A Sullenger
Journal:  Cell Chem Biol       Date:  2019-02-28       Impact factor: 8.116

Review 7.  Aptamers as targeted therapeutics: current potential and challenges.

Authors:  Jiehua Zhou; John Rossi
Journal:  Nat Rev Drug Discov       Date:  2016-11-03       Impact factor: 84.694

8.  RNA aptamers targeted for human αA-crystallin do not bind αB-crystallin, and spare the α-crystallin domain.

Authors:  Prabhat K Mallik; Hua Shi; Jayanti Pande
Journal:  Biochem Biophys Res Commun       Date:  2017-07-15       Impact factor: 3.575

Review 9.  The expanding world of DNA and RNA.

Authors:  Tingjian Chen; Narupat Hongdilokkul; Zhixia Liu; Deepak Thirunavukarasu; Floyd E Romesberg
Journal:  Curr Opin Chem Biol       Date:  2016-08-24       Impact factor: 8.822

10.  i-Clamp phenoxazine for the fine tuning of DNA i-motif stability.

Authors:  Vladimir B Tsvetkov; Timofei S Zatsepin; Evgeny S Belyaev; Yury I Kostyukevich; George V Shpakovski; Victor V Podgorsky; Galina E Pozmogova; Anna M Varizhuk; Andrey V Aralov
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.